Furthermore, Hb mass quantification is valuable in differentiating essential thrombocytosis from polycythemia vera with normal Hb and HCT, which distinction is a very important therapeutic consideration.[20,21]. This evidence concerns the gene GSTM1 and essential thrombocythemia.